Inhibin, a physiological product of ovarian follicle cells, normally a
bsent in serum of postmenopausal women, is elevated in adult granulosa
cell tumours of the ovary, Recently, high serum levels of inhibin wer
e reported in carcinomas and, surprisingly, also in Krukenberg tumours
of the ovary, This study attempted to determine the site of inhibin p
roduction in primary (111 cases), metastatic (13) and secondary (10) o
varian tumours by using immunohistochemistry. Positive staining in tum
our cells was encountered in all cases of sex-cord- stromal cell rumou
rs, adult (13) and juvenile (3) granulosa cell tumours, thecofibromas
(10), in a lipid cell tumour (1) and a Sertoli-Leydig cell tumour (1).
Primary and secondary tumours not derived from sex-cord stroma reveal
ed no positivity in tumour cells, but in theca-like cells in the surro
unding non-neoplastic ovarian stroma, A positive reaction was not obse
rved in non-tumour-bearing ovaries of a control group. The ovarian inh
ibin of postmenopausal women is derived from activated sex-cord stroma
or sex-cord-stromal neoplasms. Therefore, elevated serum inhibin conc
entrations in women with primary or secondary ovarian neoplasms with o
ther histogenesis seem to be due to an activation of the non-neoplasti
c ovarian stroma, Inhibin will fail to be a tumour marker in these cas
es. By contrast, it will be useful in proving sex-cord differentiation
by immunohistochemistry and might be used in surveillance of malignan
t sex-cord derived neoplasms by serum assays.